1. Home
  2. HALO vs CMA Comparison

HALO vs CMA Comparison

Compare HALO & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CMA
  • Stock Information
  • Founded
  • HALO 1998
  • CMA 1849
  • Country
  • HALO United States
  • CMA United States
  • Employees
  • HALO N/A
  • CMA N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CMA Major Banks
  • Sector
  • HALO Health Care
  • CMA Finance
  • Exchange
  • HALO Nasdaq
  • CMA Nasdaq
  • Market Cap
  • HALO 7.4B
  • CMA 7.1B
  • IPO Year
  • HALO N/A
  • CMA N/A
  • Fundamental
  • Price
  • HALO $52.02
  • CMA $58.81
  • Analyst Decision
  • HALO Buy
  • CMA Hold
  • Analyst Count
  • HALO 9
  • CMA 20
  • Target Price
  • HALO $63.56
  • CMA $62.95
  • AVG Volume (30 Days)
  • HALO 3.1M
  • CMA 1.5M
  • Earning Date
  • HALO 05-06-2025
  • CMA 04-21-2025
  • Dividend Yield
  • HALO N/A
  • CMA 4.83%
  • EPS Growth
  • HALO 55.40
  • CMA 4.95
  • EPS
  • HALO 3.76
  • CMA 5.29
  • Revenue
  • HALO $1,084,306,000.00
  • CMA $3,234,000,000.00
  • Revenue This Year
  • HALO $24.79
  • CMA $7.20
  • Revenue Next Year
  • HALO $22.65
  • CMA $3.01
  • P/E Ratio
  • HALO $13.83
  • CMA $11.12
  • Revenue Growth
  • HALO 25.64
  • CMA N/A
  • 52 Week Low
  • HALO $41.28
  • CMA $45.32
  • 52 Week High
  • HALO $70.51
  • CMA $73.45
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • CMA 62.43
  • Support Level
  • HALO $47.50
  • CMA $54.42
  • Resistance Level
  • HALO $69.94
  • CMA $59.36
  • Average True Range (ATR)
  • HALO 3.52
  • CMA 1.16
  • MACD
  • HALO -1.49
  • CMA 0.62
  • Stochastic Oscillator
  • HALO 19.64
  • CMA 91.83

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CMA Comerica Incorporated

With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.

Share on Social Networks: